Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English

Sleeping Pills Linked to Alzheimer's Disease Risk: Study

According to the study, regular intake of benzodiazepines may be associated with an increased risk of Alzheimer's disease.

IANS

Updated:August 16, 2018, 1:24 PM IST
facebookTwitterskypewhatsapp
Sleeping Pills Linked to Alzheimer's Disease Risk: Study
Representative Image (Image courtesy: AFP Relaxnews)
Loading...

London: Regular intake of benzodiazepines, widely used to treat insomnia and anxiety, may be associated with an increased risk of Alzheimer's disease, a study has warned.

Even though the increased risk for Alzheimer's disease was small in this study, the threshold for prescribing benzodiazepines and related drugs should be high enough due to their several adverse effects and events, such as falls, said researchers from the University of Eastern Finland.

These medications are commonly used for sleep problems, but their effectiveness for this indication diminishes over weeks or months. However, the risk of adverse events remains in longer-term use.

The results, published in Acta Psychiatrica Scandinavica, showed that the risk increase was similar with both benzodiazepines and Z drugs regardless of their half-life.

The study included all Finnish community dwellers with newly diagnosed Alzheimer's disease in 70,719 persons, and their age, sex and region of residence matched controls (282,862 persons).

Many chronic disorders, substance abuse, socioeconomical position and use of antidepressants and antipsychotics were taken into account. To account for reverse causality, drug use within 5 years before Alzheimer's disease diagnosis was not taken into account.

After adjustment for other psychotropics, it is possible that the association may partially be due to antidepressants and/or antipsychotics, or concomitant use of these medications, the researchers noted.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Subscribe to Moneycontrol Pro and gain access to curated markets data, trading recommendations, equity analysis, investment ideas, insights from market gurus and much more. Get Moneycontrol PRO for 1 year at price of 3 months. Use code FREEDOM.

| Edited by: Manila Venugopal
Read full article
Loading...
Next Story
Next Story

Also Watch

facebookTwitterskypewhatsapp

Live TV

Loading...
Countdown To Elections Results
  • 01 d
  • 12 h
  • 38 m
  • 09 s
To Assembly Elections 2018 Results